ABOUT THIS SESSION

Modern endocrinology stands on a strong foundation of time-tested and innovative therapeutic agents that have transformed diabetes and metabolic care. From traditional glucose-lowering agents to advanced cardiorenal-protective therapies, clinicians today have more tools than ever to individualize treatment and improve long-term outcomes.

Join Dr. Sanjay Kalra as he moderates a high-impact discussion with Dr. Ashu Goyal, Dr. Jaymin Somani, and Dr. Akash Ramchandani—three thought leaders representing endocrinology, nephrology, and cardiology. The discussion will highlight the complementary roles of SGLT2 inhibitors, GLP-1 receptor agonists, Metformin with Sulfonylureas, and Insulin—the true “pillars” shaping integrated cardio-renal-metabolic management.

Join this insightful session to revisit the foundations of diabetes care through the lens of contemporary evidence and multidisciplinary practice—where tradition meets innovation for better patient outcomes.